A yeast-based assay identifies drugs active against human mitochondrial disorders
- 29 June 2011
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 108 (29), 11989-11994
- https://doi.org/10.1073/pnas.1101478108
Abstract
Due to the lack of relevant animal models, development of effective treatments for human mitochondrial diseases has been limited. Here we establish a rapid, yeast-based assay to screen for drugs active against human inherited mitochondrial diseases affecting ATP synthase, in particular NARP (neuropathy, ataxia, and retinitis pigmentosa) syndrome. This method is based on the conservation of mitochondrial function from yeast to human, on the unique ability of yeast to survive without production of ATP by oxidative phosphorylation, and on the amenability of the yeast mitochondrial genome to site-directed mutagenesis. Our method identifies chlorhexidine by screening a chemical library and oleate through a candidate approach. We show that these molecules rescue a number of phenotypes resulting from mutations affecting ATP synthase in yeast. These compounds are also active on human cybrid cells derived from NARP patients. These results validate our method as an effective high-throughput screening approach to identify drugs active in the treatment of human ATP synthase disorders and suggest that this type of method could be applied to other mitochondrial diseases.Keywords
This publication has 45 references indexed in Scilit:
- TMEM70 mutations cause isolated ATP synthase deficiency and neonatal mitochondrial encephalocardiomyopathyNature Genetics, 2008
- Impact on oxidative phosphorylation of immortalization with the telomerase geneNeuromuscular Disorders, 2007
- Approaches to the treatment of mitochondrial diseasesMuscle & Nerve, 2006
- An improved map of conserved regulatory sites for Saccharomyces cerevisiaeBMC Bioinformatics, 2006
- Respiratory chain complex V deficiency due to a mutation in the assembly gene ATP12Journal of Medical Genetics, 2004
- Yeast mitochondrial oxodicarboxylate transporters are important for growth on oleic acidArchives of Biochemistry and Biophysics, 2002
- The TOR-controlled transcription activators GLN3, RTG1, and RTG3 are regulated in response to intracellular levels of glutamineProceedings of the National Academy of Sciences of the United States of America, 2002
- Identification of a Nuclear Gene (FMC1) Required for the Assembly/Stability of Yeast Mitochondrial F1-ATPase in Heat Stress ConditionsPublished by Elsevier BV ,2001
- Genetic transformation of Saccharomyces cerevisiae mitochondriaMethods in Cell Biology, 2001
- The Effect of Chlorhexidine on some Biochemical Parameters of Rat Liver MitochondriaActa Pharmacologica et Toxicologica, 1975